A review of antithrombotic treatment trials in atrial fibrillation discusses risk stratification and presents recommendations for anticoagulation to prevent stroke.
Atrial fibrillation (AF) can significantly increase morbidity and mortality. It is gaining in clinical and economic importance, being the most commonly encountered tachyarrhythmia in clinical practice. Stroke is the most serious complication. Evidence from AF antithrombotic treatment trials is reviewed, risk stratification of patients with AF is discussed, and recommendations for anticoagulation are presented.
Lip et al. (Wed,) conducted a review in Atrial fibrillation. Antithrombotic treatment was evaluated. A review of antithrombotic treatment trials in atrial fibrillation discusses risk stratification and presents recommendations for anticoagulation to prevent stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: